The Pulse of the MedTech Industry Report 2024 from EY is now available for download! While research shows that the MedTech industry is still growing, it is increasingly walking a narrow path between converging top-line and bottom-line pressures. With deep insights from EY thought leaders and perspectives from top MedTech executives on the current financing environment, capital efficiency viewpoints, what’s next in MedTech financing, and the future of innovation, the EY analysis on the state of the industry leaves no stone unturned.
Click here for details: www.ey.com/pulse
Related Reading
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q2 2026 Report
July 14, 2026
Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.
Global & Trade
AdvaMed® Resources for Venezuelan Earthquake Response
Learn how AdvaMed® member companies can support earthquake relief efforts in Venezuela through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.
Global & Trade
Support for Medical Supply and Equipment Needs in Namibia
Review Namibia’s current medical device and equipment needs and learn how interested companies can provide support for medical supply and equipment needs in Namibia.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison
Blog / Emerging Policy Response Resources / Global & Trade / Tariffs
IEEPA Tariff Refunds Summary – What MedTech Companies Need to Know
April 29, 2026
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q1 2026 Report
April 24, 2026
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
IEEPA Tariff Refunds Are Coming: What Medtech Needs to Know
Now On-Demand
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
Navigating the ACCESS & TEMPO Models: A Direct Dialogue with CMMI & FDA Leaders
On Demand
Watch AdvaMed’s® exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS & TEMPO Model. Attendees will gain critical insights into model performance metrics, payment pathways, and opportunities for the MedTech industry.